Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Rendon

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Drugs in Dermatology : JDD|April 7, 2016
Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and PhotodamageMarta Rendon, Laurence Dryer
Journal of the American Academy of Dermatology|April 25, 2006
Treatment of melasmaMarta Rendon, Mark Berneburg, Ivonne Arellano, et al.
Cutis|April 30, 2008
Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literatureJon Keeling, Lina Cardona, Adolpho Benitez, et al.
The Journal of Dermatological Treatment|July 27, 2012
Lidocaine/tetracaine peel in topical anesthesia prior to laser-assisted hair removal: Phase-II and Phase-III study resultsTina Alster, Jerome Garden, Richard Fitzpatrick, et al.
The Journal of Clinical and Aesthetic Dermatology|December 6, 2013
Open-label treatment of moderate or marked melasma with a 4% hydroquinone skin care system plus 0.05% tretinoin creamMichael Gold, Marta Rendon, Barry Dibernardo, et al.
Journal of the American Academy of Dermatology|April 25, 2006
Increasing our understanding of pigmentary disordersPearl Grimes, James J Nordlund, Amit G Pandya, et al.
Journal of the American Academy of Dermatology|March 21, 2007
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosaceaJames Q Del Rosso, Guy F Webster, Mark Jackson, et al.
Cutis|December 19, 2008
Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot studyMarta Rendon, Lina M Cardona, Eric W Bussear, et al.
Journal of Drugs in Dermatology : JDD|March 15, 2018
Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral IsotretinoinJames Q Del Rosso, Linda Stein Gold, Sandra Marchese Johnson, et al.
Journal of the American Academy of Dermatology|April 20, 2010
Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring methodAmit G Pandya, Linda S Hynan, Rafia Bhore, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Drugs in Dermatology : JDD|April 7, 2016
Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and PhotodamageMarta Rendon, Laurence Dryer
Journal of the American Academy of Dermatology|April 25, 2006
Treatment of melasmaMarta Rendon, Mark Berneburg, Ivonne Arellano, et al.
Cutis|April 30, 2008
Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literatureJon Keeling, Lina Cardona, Adolpho Benitez, et al.
The Journal of Dermatological Treatment|July 27, 2012
Lidocaine/tetracaine peel in topical anesthesia prior to laser-assisted hair removal: Phase-II and Phase-III study resultsTina Alster, Jerome Garden, Richard Fitzpatrick, et al.
The Journal of Clinical and Aesthetic Dermatology|December 6, 2013
Open-label treatment of moderate or marked melasma with a 4% hydroquinone skin care system plus 0.05% tretinoin creamMichael Gold, Marta Rendon, Barry Dibernardo, et al.
Journal of the American Academy of Dermatology|April 25, 2006
Increasing our understanding of pigmentary disordersPearl Grimes, James J Nordlund, Amit G Pandya, et al.
Journal of the American Academy of Dermatology|March 21, 2007
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosaceaJames Q Del Rosso, Guy F Webster, Mark Jackson, et al.
Cutis|December 19, 2008
Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot studyMarta Rendon, Lina M Cardona, Eric W Bussear, et al.
Journal of Drugs in Dermatology : JDD|March 15, 2018
Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral IsotretinoinJames Q Del Rosso, Linda Stein Gold, Sandra Marchese Johnson, et al.
Journal of the American Academy of Dermatology|April 20, 2010
Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring methodAmit G Pandya, Linda S Hynan, Rafia Bhore, et al.
Pageof 2